MDL Panel Strips Aredia Complaint Of Some Charges

Law360, New York (November 6, 2007, 12:00 AM EST) -- The panel on multidistrict litigation has decided to pare down a complaint recently accepted into the fold of the Aredia and Zometa product liability litigation, ruling that a number of the allegations do not relate to the bone cancer drugs at hand.

On Monday, the MDL panel issued a separation of claims and a conditional remand order in the case brought by plaintiff Margaret Nygren upon discovering that some charges involved the osteoporosis medication Actonel.

“It is therefore ordered that all claims relating to ingestion of...
To view the full article, register now.